1. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers

   • Paul Rodrigues
   • Harun Bangali
   • Ali Alsalamy

   Review Article 02 January 2024 Article: 41

   

2. Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview

   • Priyatharcini Kejamurthy
   • K. T. Ramya Devi

   Review Article 29 December 2023 Article: 40

   

3. PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients

   • Giulio Francolini
   • Angelo Porreca
   • Lorenzo Livi

   Original Paper 29 December 2023 Article: 39

   

4. Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer

   • Alaa Elmetwalli
   • Aly Nageh
   • Tarek El-Sewedy

   Original Paper 29 December 2023 Article: 38

   

5. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma

   • Abas Sezer
   • Lejla Mahmutović
   • Betül Akçeşme

   Original Paper 28 December 2023 Article: 37

   

6. Identification of hub genes to determine drug-disease correlation in breast carcinomas

   • Chiranjib Bhowmick
   • Motiur Rahaman
   • Manjunatha Mahadevappa

   Original Paper 28 December 2023 Article: 36

   

7. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs

   • Xingyu Jiang
   • Sumeng Wang
   • Lingxiang Liu

   Review Article 27 December 2023 Article: 35

   

8. Intestinal epithelial SNAI1 promotes the occurrence of colorectal cancer by enhancing EMT and Wnt/β-catenin signaling

   • Furong Qing
   • Junxia Xue
   • Zhiping Liu

   Original Paper 27 December 2023 Article: 34

   

9. USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells

   • Sicong Hou
   • Tiantian Zhao
   • Qinglei Hang

   Original Paper 27 December 2023 Article: 33

   

10. Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway

    • Ye-Mao Liu
    • An-Ding Wu
    • Wei-Ming Mao

    Original Paper 27 December 2023 Article: 32

    

11. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells

    • Merve Şansaçar
    • Helin Sağır
    • Emel Başak Gencer Akçok

    Original Paper 26 December 2023 Article: 31

    

12. The emerging role of breast cancer derived extracellular vesicles-mediated intercellular communication in ovarian cancer progression and metastasis

    • Melis Rahime Yıldırım
    • Oğuz Kaan Kırbaş
    • Ezgi Avşar Abdik

    Original Paper 26 December 2023 Article: 30

    

13. GNL3L promotes autophagy via regulating AMPK signaling in esophageal cancer cells

    • Weiting He
    • Fengyao Sun
    • Changqing Liu

    Original Paper 26 December 2023 Article: 29

    

14. Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC)

    • Nikhil Chandnani
    • Ayush Mandal
    • Koustav Sarkar

    Original Paper 25 December 2023 Article: 28

    

15. Exploring the advances of single-cell RNA sequencing in thyroid cancer: a narrative review

    • Joecelyn Kirani Tan
    • Wireko Andrew Awuah
    • Denys Ovechkin

    Review Article Open access 21 December 2023 Article: 27

    

16. Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study

    • Vanita Noronha
    • Vijay Patil
    • Kumar Prabhash

    Original Paper 21 December 2023 Article: 26

    

17. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies

    • Yalan Chen
    • Xibin Wang
    • Qian Ren

    Review Article 21 December 2023 Article: 25

18. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status

    • J. Anakha
    • Prakashkumar Dobariya
    • Abhay H. Pande

    Review Article 21 December 2023 Article: 24

    

19. Data-independent acquisition (DIA) mass spectrometry reveals related proteins involved in the occurrence of early intestinal-type gastric cancer

    • Liangshun Zhang
    • Feng Xu
    • Hua Ye

    Original Paper 19 December 2023 Article: 23

    

20. Understanding the charismatic potential of nanotechnology to treat skin carcinoma

    • Aamravi Sathe
    • Bhupendra G. Prajapati
    • Sankha Bhattacharya

    Review Article 19 December 2023 Article: 22

    

21. Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy

    • Arefeh Zabeti Touchaei
    • Sogand Vahidi
    • Ali Akbar Samadani

    Review Article 19 December 2023 Article: 21

    

22. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors

    • Ioanna Akrida
    • Francesk Mulita
    • Helen Papadaki

    Review Article 16 December 2023 Article: 20

    

23. Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy

    • Jenna Schlefman
    • Christiana Brenin
    • Patrick Dillon

    Review Article 16 December 2023 Article: 19

    

24. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit

    • Sidar Bagbudar
    • Hasan Karanlık
    • Semen Onder

    Original Paper 15 December 2023 Article: 18

    

25. KLF5 promotes esophageal squamous cell cancer through the transcriptional activation of FGFBP1

    • Fengyun Wang
    • Ming Luo
    • Yufeng Cheng

    Original Paper Open access 12 December 2023 Article: 17

    

26. What is the optimal (neo)adjuvant strategy of extremity high-risk soft tissue sarcomas (ESTS)?

    • Saoussane Kharmoum
    • Jinane Kharmoum
    • Mohammed Shimi

    Perspectives in Oncology 12 December 2023 Article: 16

27. Isolation and characterization of a novel single-chain variable fragment (scFv) against Lymphocyte function-associated antigen-1 (LFA-1) using phage display method

    • Fatemeh Afsharnoori
    • Mehdi Forouzandeh Moghadam

    Original Paper 11 December 2023 Article: 15

    

28. Development of PD-1 blockade peptide-cell conjugates to enhance cellular therapies for T-cell acute lymphoblastic leukemia

    • Quanxiao Wang
    • Hongxing Huang
    • Hua Wang

    Original Paper 11 December 2023 Article: 14

    

29. Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study

    • Sofia Paola Bianchi
    • Valeria Faccenda
    • Stefano Arcangeli

    Original Paper 11 December 2023 Article: 13

    

30. Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies

    • Alaa Elmetwalli
    • Neamat H. Kamosh
    • Tarek El-Sewedy

    Original Paper 11 December 2023 Article: 12

    

31. Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells

    • Fadime Çetin
    • Sifa Kosba
    • Zeynep Busra Bolat

    Original Paper 10 December 2023 Article: 11

    

32. Upregulation of CELSR1 expression promotes ovarian cancer cell proliferation, migration, and invasion

    • Jiwei Zuo
    • Anqi Zheng
    • Xing Du

    Original Paper 09 December 2023 Article: 10

    

33. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy

    • Rui Fu
    • Borui Zhao
    • Wei Zhou

    Review Article 08 December 2023 Article: 9

    

34. Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment

    • Ling Zhang
    • Seyed Abbas Pakmehr
    • Sepideh Karkon Shayan

    Review Article 08 December 2023 Article: 8

    

35. Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells

    • Samar A. Dewidar
    • Omar Hamdy
    • Mohamed El-Mesery

    Original Paper Open access 05 December 2023 Article: 7

    

36. The evaluation of the anti-cancer effects of Anoectochilus roxburghii on hematological cancers in vitro

    • Buket Altinok Gunes
    • Tulin Ozkan
    • Asuman Sunguroglu

    Original Paper 04 December 2023 Article: 6

    

37. Emerging treatment approaches for triple-negative breast cancer

    • Maurizio Capuozzo
    • Venere Celotto
    • Alessandro Ottaiano

    Review Article 01 December 2023 Article: 5

    

38. In vitro evaluation of p-coumaric acid and naringin combination in human epidermoid carcinoma cell line (A431)

    • Pradeep Velusamy
    • Sridhar Muthusami
    • Ramakrishnan Arumugam

    Original Paper 29 November 2023 Article: 4

    

39. Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3

    • K. T. Ramya Devi
    • M. K. Jaganathan
    • Karthick Dharshene

    Original Paper 28 November 2023 Article: 3

    

40. n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells

    • Pradnya Gurav
    • Tanvi Patade
    • R. N. Kedar

    Original Paper 28 November 2023 Article: 2

    

41. Comprehensive genomic profiling for oncological advancements by precision medicine

    • Maya Pankiw
    • Christine Brezden-Masley
    • George S. Charames

    Review Article 22 November 2023 Article: 1